TransMedics Group News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.06.22	Pre-market Movers: GTIM, BTMD, SGHC, JOAN, OKTA… (RTTNews)
04.05.22	Pre-market Movers: LYFT, ACON, LTHM, IMMP, BWV… (RTTNews)
03.05.22	TransMedics Reports First Quarter 2022 Financial Results (PR Newswire)
28.04.22	TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication (PR Newswire)
21.04.22	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
20.04.22	TransMedics to Report First Quarter 2022 Financial Results on May 3, 2022 (PR Newswire)
19.04.22	TransMedics Announces the Presentation of New OCS™ Heart and OCS™ Lung Clinical Data at the International Society of Heart and Lung Transplantation 2022 Annual Meeting (PR Newswire)
01.03.22	TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference (PR Newswire)
25.02.22	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
23.02.22	TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
22.02.22	TransMedics to Present at the Cowen 42nd Annual Healthcare Conference (PR Newswire)
09.02.22	TransMedics to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022 (PR Newswire)
06.01.22	TransMedics Announces Publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery (PR Newswire)
22.12.21	TransMedics to Present at the 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
11.11.21	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
09.11.21	TransMedics Reports Third Quarter 2021 Financial Results (PR Newswire)
04.11.21	TransMedics to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum (PR Newswire)
04.11.21	TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial (PR Newswire)
26.10.21	TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021 (PR Newswire)
29.09.21	TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation (PR Newswire)
07.09.21	TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S. (PR Newswire)
26.08.21	TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference (PR Newswire)
09.08.21	TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
05.08.21	TransMedics Reports Second Quarter 2021 Financial Results (PR Newswire)
30.07.21	TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs (PR Newswire)
28.07.21	TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference (PR Newswire)
15.07.21	FDA Panel Votes In Favor Of TransMedics' OCS Liver System (RTTNews)
15.07.21	TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System (PR Newswire)
14.07.21	TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System (PR Newswire)
10.06.21	TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting (PR Newswire)
08.06.21	TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (... (PR Newswire)
21.04.21	Stock Alert: TransMedics Group Up 11% (RTTNews)
29.09.20	Stock Alert: TransMedics Group Slips 10% After FDA Postpones Review Meeting For OCS Heart (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu TransMedics Group Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten